$13.89
-0.30[-2.11%]
At close: Mar 28
$13.89
0[0.00%]
After Hours: 4:00PM EDT
Takeda Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Takeda Pharmaceutical using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | AM | TAK | Q4 | $0.39 | — | — | — | $7.23B | — | — | — | Get Alert |
02/01/2024 | AM | TAK | Q3 | $0.59 | — | $0.51 | — | $9.65B | — | $7.88B | — | Get Alert |
10/26/2023 | AM | TAK | Q2 | $0.52 | — | $0.48 | — | $7.26B | — | $6.34B | — | Get Alert |
07/27/2023 | AM | TAK | Q1 | $0.56 | — | $0.52 | — | $7.51B | — | $7.33B | — | Get Alert |
05/11/2023 | AM | TAK | Q4 | $0.40 | — | $0.39 | — | $7.52B | — | $7.23B | — | Get Alert |
02/02/2023 | AM | TAK | Q3 | — | — | $0.59 | — | $7.93B | — | $9.65B | — | Get Alert |
10/27/2022 | AM | TAK | Q2 | $0.45 | — | $0.52 | — | $7.69B | — | $7.26B | — | Get Alert |
07/28/2022 | AM | TAK | Q1 | $0.52 | — | $0.56 | — | $8.64B | — | $7.51B | — | Get Alert |
05/11/2022 | PM | TAK | Q4 | $0.41 | — | $0.40 | — | $7.24B | — | $7.52B | — | Get Alert |
02/03/2022 | AM | TAK | Q3 | $0.54 | — | $0.52 | — | $8.01B | — | $7.93B | — | Get Alert |
10/28/2021 | AM | TAK | Q2 | $0.47 | — | $0.45 | — | $7.47B | — | $7.69B | — | Get Alert |
07/30/2021 | PM | TAK | Q1 | $0.57 | — | $0.52 | — | $7.46B | — | $8.64B | — | Get Alert |
05/11/2021 | PM | TAK | Q4 | $0.12 | — | $0.41 | — | $7.08B | — | $7.24B | — | Get Alert |
02/04/2021 | AM | TAK | Q3 | $0.53 | — | $0.54 | — | $7.91B | — | $8.01B | — | Get Alert |
10/29/2020 | AM | TAK | Q2 | $0.54 | $0.98 | $0.47 | -52.04% | $7.50B | $7.56M | $7.47B | 98722.75% | Get Alert |
07/31/2020 | AM | TAK | Q1 | $0.58 | — | $0.57 | — | $7.82B | — | $7.46B | — | Get Alert |
05/13/2020 | PM | TAK | Q4 | $0.17 | $0.43 | $0.12 | -72.09% | $6.60B | $7.48M | $7.08B | 94539.04% | Get Alert |
02/04/2020 | AM | TAK | Q3 | — | $0.32 | $0.53 | 65.62% | — | $8.14M | $7.91B | 97025.31% | Get Alert |
10/31/2019 | AM | TAK | Q2 | — | — | $0.54 | — | — | — | $7.50B | — | Get Alert |
Takeda Pharmaceutical (TAK) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on February 1, 2024 for Q3.
The Actual EPS was $0.51, which beat the estimate of $0.00.
The Actual Revenue was $7.9B, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.